DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Larazotide is an investigational drug.
There have been 4 clinical trials for Larazotide. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2018.
The most common disease conditions in clinical trials are Celiac Disease and [disabled in preview]. The leading clinical trial sponsors are Alba Therapeutics, Innovate Biopharmaceuticals, and Teva Pharmaceuticals USA.
There are two US patents protecting this investigational drug and thirty-one international patents.
Recent Clinical Trials for Larazotide
|Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Treatment of Celiac Disease||Innovate Biopharmaceuticals||Phase 3|
|A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease||Teva Pharmaceuticals USA||Phase 2|
|A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease||Alba Therapeutics||Phase 2|
Top disease conditions for Larazotide
Top clinical trial sponsors for Larazotide
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Larazotide||⤷ Try it Free||Gluten-related disorders||H.J. Heinz Company Brands LLC (Pittsburgh, PA)||⤷ Try it Free|
|Larazotide||⤷ Try it Free||Larazotide acetate compositions||Alba Therapeutics Corporation (Baltimore, MD)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Larazotide||Australia||AU2013277316||2032-06-18||⤷ Try it Free|
|Larazotide||Australia||AU2018203543||2032-06-18||⤷ Try it Free|
|Larazotide||Brazil||BR112014031666||2032-06-18||⤷ Try it Free|
|Larazotide||Canada||CA2876963||2032-06-18||⤷ Try it Free|
|Larazotide||China||CN104661671||2032-06-18||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|